Anzeige
Mehr »
Login
Samstag, 13.08.2022 Börsentäglich über 12.000 News von 669 internationalen Medien
Innocan Pharma: 15 Mal besser als der Status Quo!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2H7EV ISIN: DK0060910917 Ticker-Symbol: 1TB 
Tradegate
12.08.22
18:13 Uhr
0,231 Euro
+0,002
+0,87 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ORPHAZYME A/S Chart 1 Jahr
5-Tage-Chart
ORPHAZYME A/S 5-Tage-Chart
RealtimeGeldBriefZeit
0,2250,23312.08.
0,2260,23312.08.

Aktuelle News zur ORPHAZYME Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.06.Orphazyme A/S - 6-K, Report of foreign issuer5
29.06.ORPHAZYME A/S: Resolutions passed at the Annual General Meeting4
ORPHAZYME Aktie jetzt für 0€ handeln
28.06.Orphazyme A/S - 20-F, Annual and transition report of foreign private issuers2
21.06.Orphazyme A/S - 6-K, Report of foreign issuer2
20.06.ORPHAZYME A/S: Updated notice to holders of ADSs regarding termination of Deposit Agreement3
07.06.ORPHAZYME A/S: Notice to convene Annual General Meeting4
07.06.ORPHAZYME A/S: Orphazyme Announces Publication of 2021 Financial Results and Annual Report1
31.05.Orphazyme A/S - 6-K, Report of foreign issuer6
31.05.ORPHAZYME A/S: Orphazyme completes sale of substantially all of its assets and business activities to KemPharm12
30.05.ORPHAZYME A/S: Restructuring proposal adopted by creditors5
23.05.Orphazyme A/S - 6-K, Report of foreign issuer4
23.05.ORPHAZYME A/S: Changes to the Board of Directors9
18.05.Orphazyme to Submit Restructuring Proposal Following Asset Sales Agreement with KemPharm307(PLX AI) - Orphazyme plans to present the proposal to Danish High Court and all known creditors and will be voted on at a meeting on 30 May. • Orphazyme: if restructuring proposal is adopted by the...
► Artikel lesen
18.05.ORPHAZYME A/S: Restructuring Proposal2
17.05.KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M9
16.05.ORPHAZYME A/S: Updated Financial Calendar for 2022-
16.05.Orphazyme A/S - 6-K, Report of foreign issuer-
16.05.Orphazyme agrees to sell itself, and its 'pipeline-in-a-product,' to KemPharm2
16.05.From Redditors to creditors: Orphazyme's wild ride ends with $13M sale to satisfy bankruptcy court6
16.05.KemPharm Acquires Battered Orphazyme's Arimoclomol Program For $13M-
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1